CClinicalTrials.gg
Status unknownNCT03289377RDAD&APNsUpdated May 15, 2018

NRC:Improving Healthcare for Cognitively Impaired Elders and Their Caregivers

An interventional study of RDAD Training in Alzheimer Disease and Nurse Training, sponsored by University of Washington. Status unknown at 1 site in United States. Per ClinicalTrials.gov, last updated 2018-05-15.

Sponsored by University of Washington · Not applicable, Interventional, and Health services research

The sponsor has not verified this record recently (last verified May 2018), so the status shown — last known as Recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Not applicable
Sex
All
01

Study summary

An multi-stage mixed-method design will be employed to obtain both qualitative and quantitative data to address two study aims: (1) Evaluate and refine the delivery Reducing Disabilities in Alzheimer's Disease (RD- AD) training to advanced practice nurses and (2) Evaluate and refine the implementation of RD-AD by advanced practice nurses in their medical settings.

Read the detailed description

Two waves of APNs (25 each wave/total 50) will receive RDAD training and be queried pre and post- training using both qualitative and quantitative procedures to determine: (1) Is RDAD training successfully received by advanced practice nurses? (2) Do they report it as relevant to improving the care they deliver to persons with Alzheimer's Disease and Related Dementias (ADRD)? (3) Does RDAD training of advanced practice nurses improve their level of knowledge about ADRD, their skills in providing ADRD care, and their level of confidence in providing this care?

A subset of advanced practice nurses (5 per wave, total of 10) will be recruited to implement RDAD as part of their ongoing care of persons with ADRD.

02

Conditions studied

  • Alzheimer Disease
  • Nurse Training

Browse trials for

03

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Licensed by the Washington state Department of Health as an Advanced Registered Nurse Practitioner (ARNP),
  • Hold a board certification as a Gerontological Nurse Practitioner, Adult Nurse Practitioner, or Family Nurse Practitioner,
  • Work at least half time (0.50 FTE) in a clinical setting (primary care, internal medicine, sub-specialty, medical home), with a panel consisting of over 25% of patients over 65 years of age,
  • Have no expectation for termination over the course of the study; and
  • Agree to participate in all phases of the RDAD translational program.

Exclusion criteria

Exclusion Criteria:

  • NA
04

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
50 participants (estimated)

Study arms

  • Experimental
    RDAD training to APNs

    Half-day workshop to provide APNs with all skills necessary to conduct RDAD in their clinical settings. A subset of the trained APNs will implement RDAD as part of their ongoing care of persons with ADRD.

    Behavioral: RDAD Training

Interventions

  • BehavioralRDAD Training

    An interactive processes of lecture, role-play, and discussion, APNs will have the opportunity to dissect all phases of RDAD to insure they understand the objectives, can enact the program, and feel confident they can problem-solve situations that arise. APNs will receive materials to insure they are knowledgeable about ADRD symptoms, behavior management techniques, and exercise safety.

05

What researchers measure

Primary outcomes

  1. Physician Confidence in Dementia Care Skills

    A 12-item self-report measure (administered to ARNPs) designed to measure perception of ability to address the care needs of patients with ADRD.

    Time frame: Change from baseline score at 2 months

  2. Sense of Competence in Dementia

    A 17-item questionnaire covering 4 domains: job satisfaction, attitude towards dementia, work experience, and level of dementia knowledge.

    Time frame: Change from baseline score at 2 months

  3. Dementia Attitudes Scale

    A 20-item scale to measures attitudes towards dementia with a two-factor structure; "dementia knowledge" and "social comfort".

    Time frame: Change from baseline score at 2 months

Secondary outcomes

  1. Focus Group Questions

    Questions to determine satisfaction with a acceptability of RDAD

    Time frame: At 2 months

  2. Implementation Questions

    Questions to determine Acceptability of RDAD

    Time frame: At 2 months

06

Study locations

1 of 1 sites recruiting
  • University of Washington
    Seattle, Washington 98195, United States
    • Amy Moore Cunningham, MS · Contact · amoore@u.washington.edu · 206-616-5550
    • Linda Teri, Ph.D. · Principal investigator
    Recruiting
07

References and documents

Publications

  • Teri L, Gibbons LE, McCurry SM, Logsdon RG, Buchner DM, Barlow WE, Kukull WA, LaCroix AZ, McCormick W, Larson EB. Exercise plus behavioral management in patients with Alzheimer disease: a randomized controlled trial. JAMA. 2003 Oct 15;290(15):2015-22. doi: 10.1001/jama.290.15.2015. PubMed 14559955 ↗
  • Brodaty H, Arasaratnam C. Meta-analysis of nonpharmacological interventions for neuropsychiatric symptoms of dementia. Am J Psychiatry. 2012 Sep;169(9):946-53. doi: 10.1176/appi.ajp.2012.11101529. Erratum In: Am J Psychiatry. 2013 Feb 1;170(2):227. PubMed 22952073 ↗
  • Small GW, Rabins PV, Barry PP, Buckholtz NS, DeKosky ST, Ferris SH, Finkel SI, Gwyther LP, Khachaturian ZS, Lebowitz BD, McRae TD, Morris JC, Oakley F, Schneider LS, Streim JE, Sunderland T, Teri LA, Tune LE. Diagnosis and treatment of Alzheimer disease and related disorders. Consensus statement of the American Association for Geriatric Psychiatry, the Alzheimer's Association, and the American Geriatrics Society. JAMA. 1997 Oct 22-29;278(16):1363-71. PubMed 9343469 ↗
  • Koch T, Iliffe S; Evidem Programme. The role of primary care in the recognition of and response to dementia. J Nutr Health Aging. 2010 Feb;14(2):107-9. doi: 10.1007/s12603-010-0021-1. No abstract available. PubMed 20126958 ↗
  • Kukull WA, Higdon R, Bowen JD, McCormick WC, Teri L, Schellenberg GD, van Belle G, Jolley L, Larson EB. Dementia and Alzheimer disease incidence: a prospective cohort study. Arch Neurol. 2002 Nov;59(11):1737-46. doi: 10.1001/archneur.59.11.1737. PubMed 12433261 ↗
  • Bruce DG, Paley GA, Nichols P, Roberts D, Underwood PJ, Schaper F. Physical disability contributes to caregiver stress in dementia caregivers. J Gerontol A Biol Sci Med Sci. 2005 Mar;60(3):345-9. doi: 10.1093/gerona/60.3.345. PubMed 15860472 ↗
  • Mohamed S, Rosenheck R, Lyketsos CG, Schneider LS. Caregiver burden in Alzheimer disease: cross-sectional and longitudinal patient correlates. Am J Geriatr Psychiatry. 2010 Oct;18(10):917-27. doi: 10.1097/JGP.0b013e3181d5745d. PubMed 20808108 ↗
  • Tun SM, Murman DL, Colenda CC. Concurrent validity of neuropsychiatric subgroups on caregiver burden in Alzheimer disease patients. Am J Geriatr Psychiatry. 2008 Jul;16(7):594-602. doi: 10.1097/JGP.0b013e318173f5fc. PubMed 18591579 ↗
  • Gaugler JE, Duval S, Anderson KA, Kane RL. Predicting nursing home admission in the U.S: a meta-analysis. BMC Geriatr. 2007 Jun 19;7:13. doi: 10.1186/1471-2318-7-13. PubMed 17578574 ↗

Individual participant data

Plan to share: No

08

Registry details

Key details

Study ID
NCT03289377
Lead sponsor
University of Washington
Responsible party
Linda Teri (Professor, School of Nursing, University of Washington) — Principal investigator
First posted
Sep 21, 2017
Start date
Feb 1, 2018
Primary completion
Oct 2018 (estimated)
Completion
Oct 2018 (estimated)
Last update
May 15, 2018

Study contacts

Christine A Coulter, Ph.D.
Contact
cac76@uw.edu
206-685-9169
Amy L Cunningham, M.S.
Contact
amoore@uw.edu
206-616-5550
Linda Teri, Ph.D.
principal investigator · University of Washington

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in May 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion